Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026)
Citius Oncology (CTOR) recorded quarterly Interest & Investment Income of $43721.0 in Q1 2026, up 54.56% quarter-over-quarter from $28288.0 in Q4 2025.
Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026) Analysis & Trends
Citius Oncology's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $43721.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Citius Oncology | 68.02 Mn | 65.39 Mn | 1.34 Mn | 43,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,721.00 |
| Dec 31, 2025 | 28,288.00 |